reassuring

This from todays QVE update - QVE is a listed investment company run by IML . Anton Tagliaferro and IML are conservative value investment managers who are patient long term investors and have won countless awards. The sentiment surrounding myx is awful and its a shorters paradise. however long term patient investors should recover positions once markets return to more normal conditions in my opinion DYOR . ""Mayne Pharma declined heavily over the month after announcing a disappointing 2017 result due to a more competitive market for generics in the US in the second half of the year. While this will continue into 2018, the company is looking to offset some of this weakness through cost cutting and new product launches. The company’s branded products businesses and contract manufacturing divisions should also post better results in FY18. At current prices, we believe the company has been oversold from a long-term point of view, and while disappointed with the performance to date we are holding our position and continue to closely monitor the company’s progress""